Recent Company Performance
Trend in Sales Turnover
The company previously peaked at £35 million annual sales in 2007 and then entered a brief 2 year period of decline literally forcing our then semi retired Chairman & founder Pharmacist Gary Lewis back to leading the company from the helm as Managing Director for the second time in 2008.
Gary quickly devised an austerity plan and changes were created in company policy which has led to strong sustained annual sales growth of 7% since 2000. Record sales of £55 million and pre tax profits circa £4.3 million are expected for the financial year ending April 2016. The managing director is forecasting annual sales of £62 million and record profits in the 30th anniversary year ending April 2017
Investment in people:
The company has heavily reinvested in its people growing its team by a huge 65% in the just 4 years to a record 40 employees this combined with abolishing the UK minimum wage in favour of the significantly higher living wage sends a clear message that this is a progressive caring company that heavily reinvests in its people and their training.
Growing Financial Strength Reflecting in Improved Credit Rating:
Expecting a significant increase on the current Dun & Bradstreet 2A1 credit rating (very low risk of failure) and suggested credit of £1.71 Million (M) after the 2016 accounts are published in July 2016.
Strong Sales, Asset and Profit Growth:
Sales have grown 62% in 5 years from £32.6M to a record £55M for the year ending April 2016. Pre tax profits in 2015 have increased to a new record of £4.3M from £1.03M in 2011 and net current assets/working capital have increased by a huge 306% from £3.15M to a record £12.8M in the same 4 year period this is a testament to the huge reinvestment in the company and illustrates the leaderships confidence and investment in the future.
Awards and Recognition:
Nationally recognised with the achievement of being listed No.28 of over 2 million companies surveyed in the UK ‘Sunday Times Profit Track 100 in April 2014 and more recently the founders were joint finalists Ernest & Young Entrepreneur 2015. Recently identified in a survey by the London Stock Exchange as one of the “top 1000 most inspirational companies in Britain” of nearly 3 million companies surveyed. In 2016 listed by Grant Thornton for the 3rd successive year in the Essex top 100.
In spite of sterling(£) weakness in the final quarter of the current FY 2015/16 bullish sales are suggesting record sales of £62 million in our 30th anniversary year 2016/17 .
The directors/founders remain confident that their continued policy of reinvestment in its infrastructure and the improving skills and quality of their team will sustain healthy growth into the medium and long term. The companies highly positive cash flow and strong financial reserves are creating the opportunity and desire for merger and acquisition in 2016 onwards.
Gary and Carmen Lewis, the Founders of A1 Pharmaceuticals Plc would like to take this opportunity to thank their Team, Suppliers and indeed our customers for believing in their leadership and remaining loyal to our cause. Without the dedication and sacrifices of our people these amazing achievements would not have been possible.